Back to Agenda
Session 1: Landscape Analysis of Real World Evidence and Current Regulatory Frameworks
Session Chair(s)
Mark Stewart, PhD
Vice President, Science Policy
Friends of Cancer Research, United States
Learning Objective : At the conclusion of this session, participants should be able to:- Assess the scope of the conference
- Describe the sources of real world evidence
- Explain how RWE can contribute to drug development
Speaker(s)
FDA Update
Jacqueline A. Corrigan-Curay, JD, MD
FDA, United States
Principal Deputy Center Director, Center for Drug Evaluation and Research (CDER)
Updates on Conceptual Frameworks for Regulatory Use
Morgan Romine, MPA
Duke University, United States
Chief of Staff
Have an account?